首页> 外文期刊>TMR Non-Drug Therapy >Effects of acupoint embedding combined with clomiphene in patients with polycystic ovary syndrome: a randomized controlled trial
【24h】

Effects of acupoint embedding combined with clomiphene in patients with polycystic ovary syndrome: a randomized controlled trial

机译:穴位埋线联合克罗米芬治疗多囊卵巢综合征的疗效:一项随机对照试验

获取原文
           

摘要

Highlights Acupoint embedding combined with clomiphene could downregulate BMI, LH, and LH / FSH ratio, and increase the number of menstrual cycles in patient with polycystic ovary syndrome. Editor’s Summary The combination use of acupuncture and endocrine regulation drug has the potential to improve the function of ovarium. Objective To compare the efficacy of acupoint embedding combined with clomiphene with clomiphene alone in the treatment of patients with polycystic ovary syndrome (PCOS). Methods Sixty patients who met the diagnostic criteria of PCOS were randomly divided into the acupuncture-medicine combination (30 cases) and the single medicine (30 cases) groups. For a total of 4 menstrual cycles, patients in the acupuncture-medicine combination group were treated with acupoint embedding combined with oral clomiphene, whereas those in the single medicine group were treated with clomiphene only. Clinical efficacy of the two treatments was observed after 2 months of treatment, and body mass index (BMI), number of menstrual cycles, luteinizing hormone (LH), follicle stimulating hormone (FSH), LH / FSH ratio, and serological levels of testosterone before and after treatment were analyzed. Results Compared with the single medicine group, patients in the acupuncture-medicine group showed lower BMI (24.3 ± 1.6 vs 26.1 ± 1.8) and higher number of menstrual cycles (3.6 ± 1.5 vs 2.8 ± 1.2); the differences were statistically significant (P = 0.018, P = 0.025). LH (9.53 ± 5.46 vs 12.29 ± 5.67) and LH / FSH (1.02 ± 0.57 vs 1.45 ± 0.23) levels were significantly decreased (P = 0.041, P = 0.039). Compared to before treatment, BMI (24.3 ± 1.6 vs 27.6 ± 1.4) was lower and the number of menstrual cycles was higher (3.6 ± 1.5 vs 1.8 ± 0.8) after treatment; the differences were statistically significant (P = 0.034, P = 0.024). The levels of LH (9.53 ± 5.46 vs 18.12 ± 11.04) and LH / FSH (1.02 ± 0.57 vs 2.38 ± 1.09) were significantly decreased (P = 0.007 P = 0.005). Total effective rates were 76.67% and 70% in the acupuncture-medicine combination and single medicine groups, respectively; the difference between the two groups was statistically significant (P = 0.043). Conclusion Acupoint embedding combined with clomiphene in the treatment of PCOS could downregulate BMI, LH, and LH / FSH ratio, and increase the number of menstrual cycles.
机译:亮点穴位埋线配合克罗米芬可以下调多囊卵巢综合征患者的BMI,LH和LH / FSH比,并增加月经周期数。编者的总结针灸和内分泌调节药物的组合使用有可能改善卵巢功能。目的比较穴位埋线联合克罗米芬与克罗米芬治疗多囊卵巢综合征(PCOS)的疗效。方法将符合PCOS诊断标准的60例患者随机分为针药联用30例和单药联用30例。在总共四个月经周期中,针药组合组的患者接受穴位埋线配合口服克罗米芬治疗,而单药组的患者仅接受克罗米芬治疗。在治疗2个月后,观察了两种治疗的临床疗效,以及体重指数(BMI),月经周期数,促黄体生成激素(LH),促卵泡激素(FSH),LH / FSH比和血清睾丸激素水平分析治疗前后。结果与单药组相比,针灸组患者的BMI较低(24.3±1.6 vs 26.1±1.8),月经周期数较高(3.6±1.5 vs 2.8±1.2);差异具有统计学意义(P = 0.018,P = 0.025)。 LH(9.53±5.46 vs 12.29±5.67)和LH / FSH(1.02±0.57 vs 1.45±0.23)水平显着降低(P = 0.041,P = 0.039)。与治疗前相比,治疗后BMI(24.3±1.6 vs 27.6±1.4)更低,月经周期数更高(3.6±1.5 vs 1.8±0.8);差异具有统计学意义(P = 0.034,P = 0.024)。 LH(9.53±5.46 vs 18.12±11.04)和LH / FSH(1.02±0.57 vs 2.38±1.09)的水平显着降低(P = 0.007 P = 0.005)。针灸联用和单药组总有效率分别为76.67%和70%。两组之间的差异具有统计学意义(P = 0.043)。结论穴位埋线配合克罗米芬治疗PCOS可下调BMI,LH和LH / FSH比值,增加月经周期数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号